The University of Hong Kong: Coronary Artery Disease trials

The registry lists 12 Coronary Artery Disease studies with The University of Hong Kong as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 1Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI PerfusionRecruitingNCT07068399Not applicable
• Fullscale_Intervention Study: Genetic Risk Communication in Coronary Heart Disease and WearablesNot yet recruitingNCT05789966Not applicable
• An Internet-based Cardiac Rehabilitation Enhancement (i-CARE) Intervention to Support Self-care of Patients With Coronary Artery DiseaseRecruitingNCT04858503Not applicable
• Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)Active, not recruitingNCT07212751
• Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular DiseasesCompletedNCT06986369Phase 4
• Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance TrialCompletedNCT06671171
• Strength-building Lifestyle-integrated InterventionCompletedNCT05497687Not applicable
• Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)Active, not recruitingNCT04541797Not applicable
• Promoting Zero-time Exercise in Patients With Coronary Heart DiseaseStatus unknownNCT03464331Not applicable
• Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot StudyCompletedNCT03263728Not applicable
• A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION StudyCompletedNCT01742507Phase 4
• Direct Endomyocardial Injection of Autologous Bone Marrow Cells to Treat Ischaemic Heart FailureStatus unknownNCT01150175Phase 2